ASN002
Sponsors
Asana BioSciences
Conditions
Atopic DermatitisChronic Hand DermatitisDermatitis EczemaDermatitis, AtopicDermatitis, EczematousHealthy Volunteers
Phase 1
Phase 2
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
CompletedNCT03531957
Start: 2018-07-05End: 2019-08-14Updated: 2023-07-03
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
TerminatedNCT03654755
Start: 2018-09-29End: 2019-10-29Updated: 2023-09-18
Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema
CompletedNCT03728504
Start: 2019-01-03End: 2020-04-29Updated: 2023-05-09